The State Bank of India (SBI) has released the admit cards for the SBI PO Mains 2025 exam, scheduled for May 5. Eligible candidates can download their call letters from the official website ...

As the SBI PO Mains Exam 2025 draws near and candidates must utilize the remaining time wisely. A key step is to thoroughly read the SBI PO Mains Information Handout 2025, as it contains critical ...

Books and Authors Capsule for SBI PO Mains 2025 Moreover, for candidates targeting SBI PO Mains 2025, the Books & Authors section is another scoring area under the General Awareness section. Keeping ...

A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists—widely used in blockbuster ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, have recently gained attention for their effectiveness in managing weight gain, high blood sugar, ...

Drug-induced liver injury was reported in 1 asymptomatic patient in one of the once-daily danuglipron dose-optimization studies. Pfizer has made the decision to discontinue the clinical ...

The results of a recent national study conducted by the Arkansas Agricultural Experiment Station found that these weight loss drugs — known as Glucagon-like peptide-1 agonists or GLP-1s — lead ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), currently licensed for the treatment of type 2 diabetes mellitus and obesity, offer a novel, multilayered mechanism for intervention in ...

TET2 works with HNF4α to activate the FBP1 gene upon glucagon stimulation, while metformin disrupts TET2-HNF4α interaction, lowering FBP1 levels and improving glucose homeostasis. The results are ...

Drucker and three co-winners made discoveries about glucagon-like peptide-1 in their labs. The other recipient of the award, Lotte Bjerre Knudsen, who works for Novo Nordisk, led the way in ...